Related Experiment Videos
Genomic structure of PEX13, a candidate peroxisome biogenesis disorder gene
J Björkman1, G Stetten, C S Moore
1School of Biomolecular and Biomedical Science, Griffith University, Nathan, Brisbane, Queensland, 4111, Australia.
Insights
The human PEX13 gene, crucial for peroxisome protein import, was structurally analyzed. No mutations were found in current peroxisome biogenesis disorder patients, but PEX13 deficiency may occur rarely.
Area of Science:
- Genetics
- Molecular Biology
- Cell Biology
Background:
- Peroxisome biogenesis disorders (PBDs) are lethal genetic diseases caused by defects in peroxisomal protein import.
- PEX genes are essential for this import process, with PEX13 encoding a key docking factor.
Purpose of the Study:
- To elucidate the structure of the human PEX13 gene.
- To investigate the role of PEX13 in PBDs by assessing its ability to rescue import defects.
Main Methods:
- Gene structure analysis of human PEX13, including exon-intron boundaries and cDNA prediction.
- Functional complementation assays using PEX13 expression in PBD patient-derived fibroblast cells.
Main Results:
- The human PEX13 gene spans approximately 11 kb on chromosome 2 and comprises four exons.
- The corrected PEX13 cDNA encodes a 44,312 Da protein.
- PEX13 expression failed to rescue peroxisomal protein import defects in fibroblasts from known PBD complementation groups.
Conclusions:
- The PEX13 gene is not a frequent cause of PBDs in the studied patient cohort.
- Rare instances of PEX13 deficiency may exist in underrepresented populations or specific patient groups.
Abstract:
The peroxisome biogenesis disorders (PBDs) are a set of lethal genetic diseases characterized by peroxisomal metabolic deficiencies, multisystem abnormalities, mental retardation, and premature death. These disorders are genetically heterogeneous and are caused by mutations in genes, termed PEX genes, required for import of proteins into the peroxisomal matrix. We have previously reported the identification of human PEX13, the gene encoding the docking factor for the PTS1 receptor, or PEX5 protein. As such, mutations in PEX13 would be expected to abrogate peroxisomal protein import and result in PBD phenotypes. We report here the structure of the human PEX13 gene. PEX13 spans approximately 11 kb on chromosome 2 and contains four exons, one more than previously thought. The corrected PEX13 cDNA is predicted to encode a protein product with a molecular mass of 44,312 Da. We examined the ability of PEX13 expression to rescue the peroxisomal protein import defects of fibroblast cells representing all known PBD complementation groups. No complementation was observed, suggesting that this gene is not mutated in any set of existing patients. However, given that complementation group assignments have been determined for only a subset of PBD patients, it is possible that PEX13-deficient patients may exist at a low frequency within our existing PBD patient population or within ethnic groups underrepresented in our patient pool.